首页> 外国专利> ALPHA ENOLASE-DIRECTED DIAGNOSTICS AND THERAPEUTICS FOR CANCER AND CHEMOTHERAPEUTIC DRUG RESISTANCE

ALPHA ENOLASE-DIRECTED DIAGNOSTICS AND THERAPEUTICS FOR CANCER AND CHEMOTHERAPEUTIC DRUG RESISTANCE

机译:抗癌药和化学疗法药物的α烯醇化酶定向诊断和治疗

摘要

Disclosed are methods for detecting a neoplasm and/or chemotherapeutic drug resistance or angiogenic potential in neoplastic cells by detecting an increase in the expression of a-enolase in such cells, or in the case of metastatic potential on the surface of such cells, as compared to the level of expression of a-enolase protein in a normal or non-MDR neoplastic cell or on the surface of a non-metastatic neoplastic cell. In addition, methods and a composition are disclosed for increasing the sensitivity of a neoplasm to a chemotherapeutic drug treatment regime, for inhibiting angiogenesis and metastatic potential in chemotherapeutic drug resistant or neoplastic cells, and for inducing apoptosis in chemotherapeutic drug resistant or neoplastic cells.
机译:公开了通过检测这种细胞中α-烯醇酶表达的增加或在此类细胞表面上具有转移性的情况来检测赘生性细胞中的肿瘤和/或化疗药物抗性或血管生成潜能的方法。在正常或非MDR赘生性细胞中或在非转移性赘生性细胞表面上表达α-烯醇酶蛋白的水平。另外,公开了用于增加肿瘤对化学治疗药物治疗方案的敏感性,在化学治疗抗药性或赘生性细胞中抑制血管生成和转移潜力以及在化学治疗抗药性或赘生性细胞中诱导凋亡的方法和组合物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号